KETTLE HILL CAPITAL MANAGEMENT, LLC Adaptimmune Therapeutics plc Transaction History

KETTLE HILL CAPITAL MANAGEMENT, LLC portfolio value:

$272,000
portfolio value

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 253.13K shares 272K $1.08 253.13K